5F-AKB48: A synthetic cannabinoid presenting an emerging public health concern in France - 26/04/26
, Weniko Caré 3, 4, 5, Hervé Laborde-Casterot 3, 6, Marc Liautard 1, 2, 7, 8, Jérôme Langrand 3, 5, Laurène Dufayet 1, 2, 5, 7, 8Résumé |
Introduction |
5F-AKB48 is a potent synthetic cannabinoid with psychoactive effects. This study aimed to describe the sociodemographic and clinical characteristics of 5F-AKB48 exposures reported to French Poison Control Centers (PCCs).
Methods |
We conducted a retrospective analysis of all acute 5F-AKB48 exposure cases reported to French PCCs from 2017 to 2024. Collected data included patient demographics, symptoms, and outcomes. Poisoning severity was assessed using the Poison Severity Score (PSS).
Results |
A total of 304 cases were identified, mostly in adolescent males (median age: 16.5 years; sex ratio: 4.4). Most exposures occurred in northern France. 5F-AKB48 was used alone in 91% of cases. Of these, 59% presented with mild symptoms, 35% with moderate symptoms, and 4% with severe symptoms (including seizures, coma, and agitation). More severe outcomes were observed in cases involving multiple substances. No fatalities were reported, though the outcome was unknown in 36% of cases.
Conclusion |
5F-AKB48 appears to be an emerging recreational drug among adolescents in France, probably due to its discreet use in liquid forms compatible with e-cigarette. While most cases were mild to moderate, the potential for serious toxicity, particularly with co-exposure, should not be overlooked. The associated risks call for stronger public health measures, including stricter e-cigarettes regulation and drug education initiatives in educational settings.
Le texte complet de cet article est disponible en PDF.Plan
Vol 38 - N° 1S
P. S67 - mai 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
